RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Elizabeth Ntantie to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Elizabeth Ntantie has written about Antineoplastic Agents.
Elizabeth Ntantie
Connection Strength
0.442
Antineoplastic Agents
  1. Ntantie E, Fletcher J, Amissah F, Salako OO, Nkembo AT, Poku RA, Ikpatt FO, Lamango NS. Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer. Oncotarget. 2017 May 09; 8(19):31726-31744.
    View in: PubMed
    Score: 0.346
  2. Musa MA, Badisa VLD, Latinwo LM, Ntantie E. 7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells. Anticancer Res. 2018 Nov; 38(11):6091-6098.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support